NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 52 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,274 | -57.2% | 21,751 | +3.7% | 0.00% | – |
| Q2 2023 | $54,333 | -31.8% | 20,978 | +7.5% | 0.00% | -100.0% |
| Q1 2023 | $79,609 | -17.1% | 19,512 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $96,002 | -61.1% | 19,124 | +1.3% | 0.00% | -50.0% |
| Q3 2022 | $247,000 | +5.1% | 18,874 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $235,000 | -1.7% | 18,351 | +17.3% | 0.00% | +100.0% |
| Q1 2022 | $239,000 | -19.5% | 15,643 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $297,000 | -18.0% | 16,744 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $362,000 | +4.0% | 17,245 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $348,000 | -20.2% | 17,655 | +17.7% | 0.00% | -50.0% |
| Q1 2021 | $436,000 | +3.8% | 14,995 | +8.2% | 0.00% | 0.0% |
| Q4 2020 | $420,000 | +85.0% | 13,861 | -2.8% | 0.00% | +100.0% |
| Q3 2020 | $227,000 | -19.8% | 14,259 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $283,000 | +59.0% | 14,357 | -0.7% | 0.00% | 0.0% |
| Q1 2020 | $178,000 | -37.1% | 14,455 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $283,000 | +371.7% | 15,289 | +254.3% | 0.00% | – |
| Q3 2019 | $60,000 | -4.8% | 4,315 | +0.9% | 0.00% | – |
| Q2 2019 | $63,000 | – | 4,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $79,175,000 | 44.14% |
| Ponoi II Management, LLC | 1,298,908 | $27,303,000 | 40.46% |
| Column Group LLC | 15,396,116 | $323,626,000 | 36.81% |
| Ponoi Management, LLC | 1,298,908 | $27,303,000 | 24.24% |
| Euclidean Capital LLC | 832,274 | $17,494,000 | 8.50% |
| StepStone Group LP | 1,573,357 | $33,072,000 | 2.14% |
| Octagon Capital Advisors LP | 200,000 | $4,204,000 | 1.04% |
| Redmile Group, LLC | 2,505,118 | $52,658,000 | 0.92% |
| BVF INC/IL | 955,000 | $20,074,000 | 0.78% |
| Boxer Capital, LLC | 500,000 | $10,510,000 | 0.37% |